comScore Announces Divestiture of ARS Non-Health Copy-Testing and Equity Tracking Assets to MSW Research

Printer-friendly versionPDF version

RESTON, VA, March 18, 2013 – comScore (NASDAQ: SCOR), a leader in measuring the digital world, today announced the divestiture of its non-health copy-testing and non-health equity tracking assets of ARS to MSW Research (formerly McCollum Spielman Worldwide). MSW is a global leader in advertising research, brand health, advertising tracking, neuroscience and strategic research. The new firm will be called MSW●ARS. comScore will retain the health-based copy-testing and equity tracking assets following the divestiture.

“The divestiture of certain of our ARS assets will allow us to better focus our attention on comScore’s core growth opportunities,” said Dr. Magid Abraham, comScore President & CEO. “We thank the employees of ARS for their service and dedication as part of comScore, and wish them every success with MSW.”

The financial impact of this divesture is unchanged from expectations provided in comScore’s fourth quarter earnings announcement.

About comScore

comScore, Inc. (NASDAQ: SCOR) is a global leader in digital measurement and analytics, delivering insights on web, mobile and TV consumer behavior that enable clients to maximize the value of their digital investments. For more information, please visit www.comscore.com/companyinfo. 

Cautionary Statement

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, including, without limitation, comScore’s expectations as to the financial and operational effects of the divestiture of certain assets of comScore’s ARS unit. These statements involve risks and uncertainties that could cause our actual results to differ materially, including, but not limited to, comScore’s ability to project the financial impact of the divestiture of ARS assets and comScore’s ability to achieve its expected financial results.

For a detailed discussion of these and other risk factors, please refer to comScore’s Annual Report on Form 10-K for the period ended December 31, 2012 aand from time to time other filings with the Securities and Exchange Commission (the “SEC”), which are available on the SEC’s Web site (http://www.sec.gov).

You are cautioned not to place undue reliance on our forward-looking statements, which speak only as of the date such statements are made. comScore does not undertake any obligation to publicly update any forward-looking statements to reflect events, circumstances or new information after the date of this press release, or to reflect the occurrence of unanticipated events. 

News Source : comScore Announces Divestiture of ARS Non-Health Copy-Testing and Equity Tracking Assets to MSW Research